Evinacumab
Monoclonal antibody | |
---|---|
Type | ? |
Source | Human |
Target | angiopoietin 3 |
Identifiers | |
CAS Number | 1446419-85-7 |
ATC code | None |
ChemSpider | none |
Chemical data | |
Formula | C6480H9992N1716O2042S46 |
Molar mass | 146.1 kg/mol |
Evinacumab is a monoclonal antibody designed for the treatment of dyslipidemia.[1]
This drug was developed by Regeneron Pharmaceuticals, Inc.
References
- ↑ Statement On A Nonproprietary Name Adopted By The USAN Council - Evinacumab, American Medical Association.
|
This article is issued from Wikipedia - version of the Sunday, February 28, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.